-
Featured Press Release
During Black History Month Aspira Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities
Learn More -
Investor Event
Aspira to Participate in BTIG’s Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference; Thursday February 18, 2021 9:30am EST
Listen Here
Recent News
Choose a Category:
-
Aspira Labs Expands Coverage For Ova1® In California
Press Release
AUSTIN, Texas — ASPiRA LABS, a Vermillion company (NASDAQ: VRML), today announced an agreement has been reached with Sacramento-based Sutter Valley Medical Foundation (d/b/a Gould Medical Foundation) for coverage of OVA1, Vermillion’s ovarian cancer risk assessment test commercialized by ASPiRA LABS. “We are pleased to announce OVA1 coverage expansion with Gould Medical Foundation, a California…
-
Vermillion Reports Second Quarter 2016 Results
Press Release
AUSTIN, Texas — Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported its financial results for the second quarter ended June 30, 2016. Valerie Palmieri, President and CEO of Vermillion, Inc., stated, “We believe that our performance during the second quarter of 2016 has built a solid foundation for continued success…
-
Vermillion Lands America’s Most Decorated Gymnast and Ovarian Cancer Survivor, Shannon Miller, for its OVA1® Awareness Team
Press Release
OVA1 Awareness Team Created to Springboard a National Conversation about Pelvic Mass and the Diagnosis of Ovarian Cancer AUSTIN, Texas – Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the most decorated gymnast in American history has joined its new OVA1 Awareness Team. As a member of Vermillion’s Awareness Team,…
Upcoming Events
-
March 19 – 25, 2021
Virtual Exhibitor
Society of Gynecologic Oncology (SGO) Annual Meeting
-
April 30 – May 2, 2021
Virtual Exhibitor
American College of Obstetrics and Gynecologists Annual Meeting